Have £2,000 to invest in the FTSE 100? I’d buy these 2 bargain income stocks today

These two FTSE 100 (INDEXFTSE:UKX) dividend shares could deliver high returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The uncertain outlook for the UK economy could mean that interest rates remain at a low level for some time. In fact, there are rumours that the next move for interest rates could be downwards, with the Bank of England apparently becoming increasingly dovish as the prospects for the world economy remain challenging.

This could mean that dividend stocks offer increasingly appealing outlooks when compared to other mainstream assets. As such, now could be the right time to buy these two FTSE 100 income shares. They may deliver high income returns, as well as capital growth, over the long run.

GSK

The outlook for GSK (LSE: GSK) and the wider pharmaceuticals industry could improve significantly over the long run. Demand for healthcare-related products and services may rise due to an ageing global population, which could mean that the company’s decision to focus on its pharmaceutical operations leads to an improving rate of profit growth.

However, an improving financial outlook may take time to achieve. In the current year, GSK is forecast to post a fall in earnings of 3%, while growth of 2% in the next financial year may mean that investors struggle to become increasingly bullish about the stock from a growth perspective over the near term.

Of course, its defensive characteristics may boost its appeal in the short run. GSK’s lack of dependence on the wider economy for its growth could lead to increasing demand among investors who could become increasingly risk-averse. Since it offers a dividend yield of around 4.6%, its total returns may therefore be highly attractive.

As such, now could be a good time to buy the stock, with its income prospects, defensive appeal and long-term growth potential suggesting that it may outperform the FTSE 100.

Rio Tinto

Unlike GSK, FTSE 100 index peer Rio Tinto (LSE: RIO) lacks defensive appeal. Its financial performance is closely linked to the prospects for the world economy. Since there are concerns surrounding the outlook for China due in part to the global trade war, it would be unsurprising for the stock’s valuation to come under a degree of pressure in the near term.

However, Rio Tinto’s current valuation suggests that investors may have factored in many of the risks facing the business. It currently trades on a price-to-earnings (P/E) ratio of just 8, which indicates that it has a wide margin of safety. With the company having a relatively low level of gearing, it could prove to be more resilient than some of its sector peers should the performance of the world economy disappoint.

The stock’s dividend yield of 6.9% suggests that it could offer income investing potential over the long run. While there may be more stable income opportunities elsewhere in the FTSE 100, the iron ore miner may be able to produce a high overall return for patient investors.

Peter Stephens owns shares of GlaxoSmithKline and Rio Tinto. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

ISA coins
Investing Articles

£10,000 put in a Cash ISA a decade ago is now worth…

What would have made someone the most money over the past 10 years -- a Cash ISA or Stocks and…

Read more »

A man with Down's syndrome serves a customer a pint of beer in a pub.
Investing Articles

Are Diageo shares about to pull a Rolls-Royce?

On many metrics, Diageo shares are looking somewhat similar to Rolls-Royce shares a few years back. Could history repeat itself?

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

1 big question to ask when thinking about what Nvidia stock could be worth

Christopher Ruane likes the look of the Nvidia business. But when it comes to its stock price, he's taking a…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

How has the Scottish Mortgage Investment Trust share price risen 57% in a year?

The Scottish Mortgage share price has soared over the last 12 months. After this kind of gain, investors might be…

Read more »

A young black man makes the symbol of a peace sign with two fingers
Investing Articles

I just bought this magnificent £2 UK growth stock for my Stocks and Shares ISA

Edward Sheldon just bought shares in this fast-growing British company for his Stocks and Shares ISA and he’s excited about…

Read more »

British pound data
Investing Articles

The stock market could plummet says the Bank of England

The Bank of England sees a number of risks on the horizon that could derail the stock market’s recent rally.…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Here’s how a £20,000 Stocks and Shares ISA could one day generate £14,947 of passive income a year

Can a five-figure Stocks and Shares ISA end up producing a five-figure annual passive income? This writer shows how it…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

5 years ago £10k bought 4,484 Tesco shares. How many would it buy today?

Harvey Jones is astonished by how well Tesco shares have done lately. Can the FTSE 100 stock continue its strong…

Read more »